TY  - BOOK
TI  - DCF Valuation of Pharmaceutical Companies
U1  - WIN/2024/FIN-SPE/PR5951 
PY  - 2024///
CY  - Mumbai
PB  - SFIMAR
KW  - FIN-SPE
KW  - DCF Valuation of Pharmaceutical Companies
ER  -